BioGX

From Bhamwiki
Jump to: navigation, search

BioGX is a molecular diagnostics company headquartered at 2450 Valleydale Road. The company also operates a second manufacturing and distribution center, BioGX BV, in Amsterdam, the Netherlands.

BioGX was founded in 2007 by Michael Vickery and was located in Birmingham's Innovation Depot until purchasing its present 30,000 square-foot building in 2021. Shazi Iqbal has served as CEO since 2011. Both are veterans of the Sunnyvale, California-based Cepheid Inc.

BioGX partnered with Becton Dickinson & Co. of New Jersey to develop a rapid COVID-19 RNA test for its "BD Max" diagnostic platform. The test was granted an emergency use authorization from the U.S. Food and Drug Administration in April 2020. It's "XFree" test process was given the same type of approval in October.

References

External links